IP Library Granted Patent US 11,034,994
Granted Patent B2
US 11,034,994 · App. 15/967,216 · Granted Jun 15, 2021

In vivo detection of phospholipase activation

Inventors: Edward J. Delikatny (Havertown, PA); Anatoliy V. Popov (Philadelphia, PA); Gang Zheng (Toronto, CA); Theresa Mawn (Philadelphia, PA)
Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
C12Q1/61A61K49/0036G01N33/5011G01N33/542G01N33/57484A61K41/0071A61K49/0017A61K49/0032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,034,994
App. No.
15/967,216
Granted
Jun 15, 2021
Kind
B2
Abstract

The present invention is directed to a phospholipid-based NIR molecular beacon, having a phospholipid moiety; with an NIR fluorophore moiety covalently linked to a phospholipid glycerol backbone and a quencher moiety covalently linked to the phospholipid glycerol backbone. Additionally, provided herein is methods of analyzing a sample for the presence of a phospholipase and methods of identifying the activity of a phospholipase in vivo utilizing phospholipid-based NIR molecular beacon.

Claims (14)

1. A method of analyzing a sample for the presence of a phospholipase, the method comprising:

contacting a sample suspected of comprising a phospholipase with a phospholipid-based near infrared (NIF) molecular beacon comprising (i) a phospholipid moiety with a glycerol backbone; (ii) a first fluorophore moiety covalently linked to the glycerol backbone either directly or via a linker, wherein said first fluorophore moiety is an NIR fluorophore moiety; and (iii) a fluorescence quencher moiety covalently linked to said phospholipid glycerol backbone either directly or via a linker, wherein the fluorophore moiety, the fluorescence quencher moiety or both are uncharged when covalently linked at either or both sn-1 or sn-2 fatty acyl positions; and

detecting the NIR fluorescence of said NIR fluorophore moiety as a function of time, wherein an increase in the NIR fluorescence as a function of time correlates with the presence of the phospholipase in the sample.

2. The method of claim 1 , wherein said NIR fluorophore is covalently bound to the glycerol backbone at either the sn-1 or sn-2 fatty acyl positions or to the sn-3 head group.

3. The method of claim 2 , wherein said quencher moiety is a second fluorophore covalently bound to the remaining unbound fatty acyl position or the sn-3 head group.

4. The method of claim 3 , wherein said second fluorophore moiety or quencher moiety is covalently linked to the phospholipid moiety either directly or via a linker.

5. The method of claim 1 , wherein said sample is a tumor cell or an extract of a tumor cell.

6. The method of claim 1 , wherein said sample is a cultured cell, a primary cell culture or their combination.

7. A method of monitoring the activity of a phospholipase in vivo, comprising the steps of:

exposing a tissue to a phospholipid-based near infrared (NIR) molecular beacon under conditions effective to permit said phospholipase to cleave said beacon, wherein said beacon comprises (i) a phospholipid moiety with a glycerol backbone; (ii) a first fluorophore moiety covalently linked to the glycerol backbone either directly or via a linker, wherein said first fluorophore moiety is an NIR fluorophore moiety; and (iii) a fluorescence quencher moiety covalently linked to said phospholipid glycerol backbone either directly or via a linker, wherein the fluorophore moiety, the fluorescence quencher moiety or both are uncharged when covalently linked at either or both sn-1 or sn-2 fatty acyl positions; and

detecting the fluorescence of said fluorophore moiety as a function of time, wherein an increase in the quantity or rate of accumulation of fluorescence as compared to a control reaction identifies the activity of the phospholipase.

8. The method of claim 7 , wherein said NIR fluorophore is covalently bound to the glycerol backbone at either the sn-1 or sn-2 fatty acyl positions or to the sn-3 head group.

9. The method of claim 8 , wherein the quencher moiety is a second fluorophore covalently bound to the remaining unbound fatty acyl position or the sn-3 head group.

10. The method of claim 9 , wherein said second fluorophore moiety or quencher moiety is covalently linked to the phospholipid moiety either directly or via a linker.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2019
From: DELIKATNY, EDWARD J.; POPOV, ANATOLIY V.; ZHENG, GANG; MAWN, THERESA
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 049859/0376 →
CONFIRMATORY LICENSE Recorded Jan 22, 2019
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 049638/0316 →
Continuity (3)
Division 12920451
Provisional Application 61064404 · Mar 4, 2008
Related Publication 20180245129A1 · Aug 30, 2018